Skip to main content
NIH funding notice PAR-21-274

Cancer Target Discovery and Development (CTD2) (U01 Clinical Trial Not Allowed)

Closed on October 6, 2022.

Posted
July 12, 2021
Close date
October 6, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,878,097 in first-year total cost, median $969,145.

Most frequent study sections

  1. Special Emphasis Panel[ZCA1 RPRB-N (M2)]3
  2. Special Emphasis Panel[ZCA1 SRB-P (M1)]3
  3. Special Emphasis Panel[ZCA1 TCRB-V (A1)]1

Most frequent institutions

  1. BROAD INSTITUTE, INC.1
  2. COLUMBIA UNIVERSITY HEALTH SCIENCES1
  3. FRED HUTCHINSON CANCER CENTER1
  4. ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
  5. OREGON HEALTH & SCIENCE UNIVERSITY1
Competing awards under PAR-21-274 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023A Patient-Centric Approach to Advance Functional Precision Oncology1U01CA282109-01KEMP, CHRISTOPHER JFRED HUTCHINSON CANCER CENTER, WA$1,098,796ZCA1
2023Spatial functional genomics to identify regulators of the tumor microenvironment and cancer immunity1U01CA282114-01BROWN, BRIAN DMERAD, MIRIAMSAMSTEIN, ROBERT MICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY$1,032,278ZCA1
2023Identifying and targeting collateral lethal vulnerabilities in cancers1U01CA275886-01DEPINHO, RONALD ANTHONYHART, GLEN TRAVERUNIVERSITY OF TX MD ANDERSON CAN CTR, TX$967,038ZCA1
2023Systematic Characterization and Targeting of Neomorphic Drivers in Cancer1U01CA281902-01DENEEN, BENJAMINLIANG, HANMILLS, GORDON B.OREGON HEALTH & SCIENCE UNIVERSITY, OR$883,656ZCA1
2022Elucidating and Targeting tumor dependencies and drug resistance determinants at the single cell level1U01CA272610-01CALIFANO, ANDREACOLUMBIA UNIVERSITY HEALTH SCIENCES, NY$991,182ZCA1
2022Bay Area Cancer Target Discovery and Development1U01CA272546-01BANDYOPADHYAY, SOURAVBIVONA, TREVER GMCMANUS, MICHAEL TWEISSMAN, JONATHAN S.UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA$969,145ZCA1
2022Translating novel cancer targets and mechanisms from the CTD^2 Network using molecular glues1U01CA272612-01CLEMONS, PAUL ANDREWSCHREIBER, STUART LBROAD INSTITUTE, INC., MA$936,002ZCA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.